# Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)

> **NCT04597450** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 35 (actual)

## Conditions studied

- PTSD

## Interventions

- **DRUG:** Lu AG06466
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04597450
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-30
- **Primary completion:** 2023-02-13
- **Final completion:** 2023-02-13
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04597450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04597450, "Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04597450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*